geraniol has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rekha, KR; Santha, K; Selvakumar, GP; Sethupathy, S; Sivakamasundari, RI | 1 |
| Inmozhi Sivakamasundari, R; Rekha, KR; Santha, K; Selvakumar, GP | 1 |
2 other study(ies) available for geraniol and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Geraniol ameliorates the motor behavior and neurotrophic factors inadequacy in MPTP-induced mice model of Parkinson's disease.
Topics: Acyclic Monoterpenes; Animals; Brain-Derived Neurotrophic Factor; Dopaminergic Neurons; Glial Cell Line-Derived Neurotrophic Factor; Lipid Peroxidation; Locomotion; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; RNA, Messenger; Terpenes | 2013 |
Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Acyclic Monoterpenes; alpha-Synuclein; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Lewy Bodies; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; MPTP Poisoning; Neuromuscular Diseases; Parkinson Disease, Secondary; Substantia Nigra; Terpenes | 2013 |